Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Steegmann, Juan Luis
82  Ergebnisse:
Personensuche X
?
1

Hepatotoxicity as dose-limiting toxicity of the combination..:

Pérez-Lamas, Lucía ; de Paz Arias, Raquel ; Díaz, Rosa Mª Ayala...
Annals of Hematology.  , 2024
Link: https://doi.org/10.1007/..
 
?
2

Cytotoxic cell populations developed during treatment with ..:

Vigón, Lorena ; Rodríguez-Mora, Sara ; Luna, Alejandro...
Biochemical Pharmacology.  182 (2020)  - p. 114203 , 2020
Link: https://doi.org/10.1016/..
 
?
3

Cutaneous side effects in a cohort of patients with chronic..:

Llamas‐Velasco, Mar ; Ovejero‐Merino, Enrique ; García‐Diez, Amaro...
Dermatologic Therapy.  33 (2020)  6 - p. , 2020
Link: https://doi.org/10.1111/..
 
?
4

Identification of Immunological Parameters as Predictive Bi..:

Vigón, Lorena ; Luna, Alejandro ; Galán, Miguel...
Journal of Clinical Medicine.  10 (2020)  1 - p. 42 , 2020
Link: https://doi.org/10.3390/..
 
?
5

CD4 T cells from patients with chronic myeloid leukemia are..:

Vigón, Lorena ; Rodríguez-Mora, Sara ; Mateos, Elena...
Journal of Virus Eradication.  5 (2019)  - p. 53 , 2019
Link: https://doi.org/10.1016/..
 
?
6

Immediate Effects of Dasatinib on the Migration and Redistr..:

Colom-Fernández, Beatriz ; Kreutzman, Anna ; Marcos-Jiménez, Ana...
Frontiers in Pharmacology.  10 (2019)  - p. , 2019
Link: https://doi.org/10.3389/..
 
?
7

Evaluation of resistance to HIV-1 infection ex vivo of PBMC..:

Bermejo, Mercedes ; Ambrosioni, Juan ; Bautista, Guiomar...
Biochemical Pharmacology.  156 (2018)  - p. 248-264 , 2018
Link: https://doi.org/10.1016/..
 
?
8

Drug-to-drug interactions of tyrosine kinase inhibitors in ..:

On behalf of the CML Spanish Group (GELMC) ; Osorio, Santiago ; Escudero-Vilaplana, Vicente...
Annals of Hematology.  97 (2018)  11 - p. 2089-2098 , 2018
Link: https://doi.org/10.1007/..
 
?
9

Feasibility of treatment discontinuation in chronic myeloid..:

Hernández-Boluda, Juan Carlos ; Pereira, Arturo ; Pastor-Galán, Irene...
Blood Cancer Journal.  8 (2018)  10 - p. , 2018
Link: https://doi.org/10.1038/..
 
?
10

Impact of age on efficacy and toxicity of nilotinib in pati..:

Giles, Francis J. ; Rea, Delphine ; Rosti, Gianantonio...
Journal of Cancer Research and Clinical Oncology.  143 (2017)  8 - p. 1585-1596 , 2017
Link: https://doi.org/10.1007/..
 
?
11

Correction to: An analysis of the kinetics of molecular res..:

Steegmann, Juan Luis ; Colomer, Dolors ; Gómez-Casares, Maria-Teresa...
Journal of Cancer Research and Clinical Oncology.  144 (2017)  1 - p. 187-188 , 2017
Link: https://doi.org/10.1007/..
 
?
12

An analysis of the kinetics of molecular response during th..:

Steegmann, Juan Luis ; Colomer, Dolors ; Gómez-Casares, Maria-Teresa...
Journal of Cancer Research and Clinical Oncology.  143 (2017)  10 - p. 2059-2066 , 2017
Link: https://doi.org/10.1007/..
 
?
13

PTCH1 is a reliable marker for predicting imatinib response..:

Alonso-Dominguez, Juan M. ; Casado, Luis Felipe ; Anguita, Eduardo...
PLOS ONE.  12 (2017)  7 - p. e0181366 , 2017
Link: https://doi.org/10.1371/..
 
?
14

The OPTIC Study: a Multi-Center, Randomized Phase 2 Trial w..:

Gutierrez, Valentin García ; Cortes, Jorge ; Deininger, Michael...
Clinical Lymphoma Myeloma and Leukemia.  16 (2016)  - p. S59-S60 , 2016
Link: https://doi.org/10.1016/..
 
?
15

Bosutinib shows low cross intolerance, in chronic myeloid l..:

García‐Gutiérrez, Valentín ; Martinez‐Trillos, Alejandra ; Lopez Lorenzo, Jose Luis...
American Journal of Hematology.  90 (2015)  5 - p. 429-433 , 2015
Link: https://doi.org/10.1002/..
 
1-15